Enveric Biosciences Reports Financial Results for Third Quarter 2026 and Provides Corporate Update

Enveric Biosciences Inc. (ENVB) — CAMBRIDGE, Mass., November 13, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today reported financial results for the third quarter ended September 30, 2026, and provided a comprehensive business update.

Source: Business Wire — read the full announcement there.

Browse more sector announcements in our press release archive.